Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial. [electronic resource]
Producer: 20160407Description: 809-17 p. digitalISSN:- 1539-3704
- Adult
- Aged
- Antiviral Agents -- adverse effects
- Carbamates -- adverse effects
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Heterocyclic Compounds, 4 or More Rings -- adverse effects
- Humans
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- RNA, Viral -- blood
- Ribavirin -- adverse effects
- Sofosbuvir -- adverse effects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.